Winding up a decade of junk science
By Doug Bandow
Copyright 1999 Washington Times
May 8, 1999
The 1990s will be remembered for many things. None may be more
important than 
the Decade of 
Junk Science.
The purpose of tort law is to compensate those who are
injured through the 
negligence of others. Necessary is proof both that the plaintiff
was injured 
and that the defendant was at fault. 
Unfortunately, skillful lawyers hire experts who say
anything and torture 
statistics to confess to everything. The result has been a rash of
dubious 
mass torts - Bendectin, Norplant, silicone breast implants, among
others - 
yielding huge damages for nonexistent harms.
Indeed, the incentive to use 
junk 
science is overwhelming. As George Mason University law Professor
David Bernstein 
observes in a new article in the California Law Review:
"Phantom risk litigation feeds on political
manipulation, baseless media scare 
stories, unthinking public outrage and plaintiffs' attorneys'
financial 
incentives to bring speculative but potentially highly remunerative
cases."
Among the worst examples is breast implant litigation,
which has become one of 
the great legal deluges in history, with thousands of women filing
suit. An 
entire industry essentially collapsed as a result; Dow Corning was
forced to 
file for bankruptcy protection. Debate over the issue, writes Mr.
Bernstein, 
"reverberates in legal and political circles."
Yet hardly a day goes by without further evidence that the
scientific case 
against silicone implants has collapsed. Not that that should come
as any 
surprise. Mr. Bernstein's 
essay reviews Marcia Angell's 
"Science on Trial: The Clash of Medical Evidence and the
Law," which first appeared three years ago.
Miss Angell, executive editor of the New England Journal of
Medicine, warned 
that 
"there was almost no reliable scientific information at the
time of the ban" by the Food and 
Drug Administration. Instead, FDA head David Kessler made a purely
political 
decision, one that was ably exploited by entrepreneurial attorneys.
Since then, a score of serious, peer-reviewed studies
conducted by researchers 
at such institutions as Harvard University, Johns Hopkins
University, the 
Mayo Clinic, and the University of Michigan, among others, have
found an 
insubstantial to nonexistent connection between silicone implants
and disease. 
Moreover, one report concluded that as a group, women who had
received implants 
were at higher risk to a variety of health problems.
Every major survey 
sparked by the legal deluge has gone the same way. For instance,
last summer 
the European Committee on Quality Assurance and Medical Devices in
Plastic 
Surgery reported the evidence was 
"conclusive" that implants did not cause autoimmune or
connective tissue diseases, and that 
"there is no scientific evidence" of other 
silicone maladies. These opinions were backed by a report from the
Independent 
Review Group, established by the British government.
A four-member expert panel appointed by U.S. District Court
Judge Samuel 
Pointer reached a similar conclusion last December. It reported, 
"No association was evident between breast implants and any of
the individual 
connective tissue diseases, all definite connective diseases
combined, or the 
other autoimmune/rheumatic conditions."
None of this means that many, if not most, plaintiffs were
not ill. But there 
is no evidence implants are at fault. As Miss 
Angell puts it: Women have 
"been told they might get sick because of the implants.
They've developed 
symptoms that any women over 25 could develop."
Because the evidence was so overwhelming, the vast majority
of court cases have 
gone for the defendants. But that doesn't mean justice was done. As
Mr. 
Bernstein points 
out, 
"sometimes a lawyer can win just by getting the game in play.
Deterred by the 
possibility of large awards by unpredictable juries, high legal
costs and the 
notoriety of a trial, many defendants can be induced to offer huge
settlements."
Unfortunately, it is too 
late to undo the damage suffered by implant makers. But judicial
and 
legislative reform could prevent a repeat performance in another
industry.
Judges have begun to act. In 1993, the Supreme Court
decided in Daubert vs. 
Merrell Dow Pharmaceuticals that judges must weigh the 
"scientific validity" of expert evidence. The justices
reinforced that decision in Kumho Tire Co. 
vs. Carmichael last month, when they ruled that Daubert applies to 
nonscientific expert testimony.
Legislators also could help end abusive litigation. Perhaps
the most important 
step would be to inaugurate the so-called English rule, which 
requires losers to pay the legal expenses of the winners. That way
litigants 
relying on 
junk science would be held responsible for filing frivolous
lawsuits.
A well-functioning liability system is critical for both a
just society and an 
efficient economy. But a badly 
functioning one can have catastrophic consequences, as evidenced by
the Decade 
of 
Junk Science.
Doug Bandow is a senior fellow at the Cato Institute.
Comments on this posting?
Click here to
post a public comment on the Trash Talk
Bulletin Board.
Click here to send a private
comment to the Junkman.